Time to treatment for women with chlamydial or gonococcal infections: a comparative evaluation of sexually transmitted disease clinics in 3 US cities.
BACKGROUND
Many women with positive screening tests for chlamydia or gonorrhea are not promptly treated and are at risk for complications and further disease transmission. Improved methods for notifying infected patients might increase timely treatment in this population.


OBJECTIVE
Describe notification procedures at STD clinics in Washington, DC; Los Angeles; and San Diego and compare timeliness of treatment during 2000 to 2002.


METHODS
Interviews were conducted to determine methods for notifying infected patients. Data were abstracted from 327 medical records of women with chlamydia or gonorrhea who had not been treated presumptively. The interval between specimen collection and treatment ("time to treatment") was calculated.


RESULTS
Each clinic had different procedures for notifying untreated infected women. Among those treated, the median time to treatment was 18 days in Washington, DC, and 8 days in Los Angeles. In San Diego, the median time to treatment was initially 14 days, which improved to 7 days after patient-notification procedures were changed.


CONCLUSIONS
Simple changes in patient notification procedures can decrease time to treatment at STD clinics. STD programs should evaluate time to treatment and institute methods for efficient patient follow-up.
Wong
David
D
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. acq6@cdc.gov
Berman
Stuart M
SM
Furness
Bruce W
BW
Gunn
Robert A
RA
Taylor
Melanie
M
Peterman
Thomas A
TA
D000328:Adult; D002140:California / Q000453:epidemiology; D002690:Chlamydia Infections / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D002692:Chlamydia trachomatis / Q000302:isolation & purification*; D016358:Contact Tracing / Q000379:methods*; D004219:District of Columbia / Q000453:epidemiology; D005260:Female; D006069:Gonorrhea / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007407:Interviews as Topic; D008499:Medical Records; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification*; D017063:Outcome Assessment, Health Care; D012189:Retrospective Studies; D013997:Time Factors
Am J Obstet Gynecol. 1991 Jun;164(6 Pt 2):1771-81
2039031
Sex Transm Dis. 1999 Oct;26(9):496-9
10534201
JAMA. 1994 Sep 21;272(11):867-70
8078164
MMWR Recomm Rep. 2002 Oct 18;51(RR-15):1-38; quiz CE1-4
12418541
Am J Public Health. 2003 Jun;93(6):882-4
12773344
Sex Transm Dis. 1997 Nov;24(10):587-92
9383848
Sex Transm Dis. 1997 Mar;24(3):131-41
9132979
Sex Transm Dis. 1990 Jan-Mar;17(1):10-4
2106171
J Clin Microbiol. 2002 Oct;40(10):3757-63
12354877
Sex Transm Dis. 1999 Apr;26(4):232-40
10225593
Am J Obstet Gynecol. 1997 Jan;176(1 Pt 1):103-7
9024098
Sex Transm Dis. 1999 Sep;26(8):421-5
10494931
Sex Transm Dis. 1997 Apr;24(4):181-4
9101628